Boston-based #biotech and #pharma reporter writing for C&EN @cenmag

Search Tweets

Twitter Feed

@RLCscienceboss — 512 followers, 589 tweets

RT @NIHDirector: I am excited about the potential for CRISPR/Cas9 to cure #sicklecell disease, maybe even in the next 5 years. This… https://t.co/aUfIR9LJ18
@emilylmullin This has happened to me too in the past few months! Except I still drink coffee, but I substitute more tea for less coffee throughout the day and evening, haha. The coffee caffeine jitters finally caught up to me I guess.
RT @AndyBiotech: This is probably the most interesting tidbit from $SLDB S-1 Gene therapy pioneer Penn's James Wilson resigned from… https://t.co/dSJzPtWKwA
Pandion Therapeutics launches today with $58 million in funding to create #bispecific #antibodies for #autoimmune and inflammatory diseases. Their key selling point is designing drugs for immunomodulation, not immunosuppression. Story for @cenmag here:  https://cen.acs.org/articles/96/i4/Pandion-Therapeutics-launches-58-million.html 
Show More